Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05079620 · ClinicalTrials.gov registry record · Phase 4
Early Antibiotics After Aspiration in ICU Patients
A Phase 4 study, sponsored by UConn Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT05079620 is a Phase 4 study that was terminated before completion, run by UConn Health. The registered enrollment target is 5 participants.
The verdict
NCT05079620, a Phase 4 study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.
Interventions
- DRUG Vancomycin
- DRUG Ceftriaxone
- DRUG Cefepime
- DRUG Levofloxacin
- DRUG Amoxicillin clavulanic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2024-04-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05079620
The ClinicalTrials.gov registry entry for NCT05079620 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Vancomycin is the first listed.
NCT05079620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05079620 about?
NCT05079620 is a clinical study titled "Early Antibiotics After Aspiration in ICU Patients". The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.
What is the current status of trial NCT05079620?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2021-11-30. Estimated completion is 2024-04-12.
What interventions are being tested in trial NCT05079620?
The interventions under investigation include: Vancomycin (DRUG), Ceftriaxone (DRUG), Cefepime (DRUG), Levofloxacin (DRUG), Amoxicillin clavulanic acid (DRUG).
Who is sponsoring clinical trial NCT05079620?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.